Catalog Home Page

Publications: Berry, Cassandra

Stats for Berry, Cassandra
Export as [feed] RSS
Group by: Publication Type | Year
Number of items: 34.

Journal Article

Rinaldi, C., Penhale, W.J., Stumbles, P.A., Tay, G. and Berry, C.M. (2014) Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis. PLoS ONE, 9 (2).

Le, X., Poinern, G.E.J., Ali, N., Berry, C.M. and Fawcett, D. (2013) Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. International Journal of Biomaterials, 2013 . pp. 1-16.

Poinern, G.E.J., Ali, N., Berry, C., Singh, P., Berchmans, S. and Fawcett, D. (2012) Biocompatibility of synthesised nano-porous anodic Aluminium oxide membranes for use as a cell culture substrate for Madin-Darby Canine Kidneys cells: A preliminary study. Journal of Tissue Science & Engineering, 3 (3).

Berry, C.M., Hertzog, P.J. and Mangan, N.E. (2012) Interferons as biomarkers and effectors: lessons learned from animal models. Biomarkers in Medicine, 6 (2). pp. 159-176.

James-Berry, C.M. (2012) Vaccine control of avian influenza H5N1 in poultry: Need for a positive marker. Journal of Vaccines & Vaccination, 04 (01). p. 168.

Bayer, W., Lietz, R., Ontikatze, T., Johrden, L., Tenbusch, M., Nabi, G., Schimmer, S., Groitl, P., Wolf, H., Berry, C.M., Überla, K., Dittmer, U. and Wildner, O. (2011) Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology, 8 (1). p. 75.

Chua, T-H, Leung, C.Y.H., Fang, H. E., Chow, Ch-K, Ma, S-K, Sia, S-F, Ng, I.H.Y., Fenwick, S.G., James, C.M., Chua, S.B., Chew, S.T., Kwang, J., Peiris, J.S.M. and Ellis, T.M. (2010) Evaluation of a subunit H5 vaccine and an inactivated H5N2 avian influenza marker vaccine in ducks challenged with Vietnamese H5N1 highly pathogenic avian influenza virus. Influenza Research and Treatment, 2010 . pp. 1-10.

James-Berry, C.M., Middleton, D., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2010) Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine. Veterinary Record, 167 (18). pp. 695-699.

Gerlach, N., Gibbert, K., Alter, C., Nair, S., Zelinskyy, G., James, C.M. and Dittmer, U. (2009) Anti-retroviral effects of type I IFN subtypes in vivo. European Journal of Immunology, 39 (1). pp. 136-146.

Eade, J.A., Robertson, I.D. and James-Berry, C.M. (2009) Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats. Reproduction, 137 (6). pp. 913-922.

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Vind, A.R., Fenwick, S.G. and Ellis, T.M. (2008) Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine, 26 (42). pp. 5345-5351.

James, C.M., Duffy, S., Pemberton, D., Armson, A. and Stumbles, P. (2008) Interferon subtype stimulation of dendritic cells: Key activators of anti-viral immunity. Cytokine, 43 (3). p. 309.

James-Berry, C.M., Abdad, M.Y., Mansfield, J.P., Jacobsen, H.K., Vind, A.R., Stumbles, P.A. and Bartlett, E.J. (2007) Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. Vaccine, 25 (10). pp. 1856-1867.

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2007) Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine, 25 (31). pp. 5892-5901.

Austin, B.A., James-Berry, C.M., Härle, P. and Carr, D.J.J. (2006) Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality. Biological Procedures Online, 8 (1). pp. 55-62.

Austin, B.A., James, C., Silverman, R.H. and Carr, D.J.J. (2005) Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-β during acute ocular herpes simplex virus type 1 infection. Journal of Immunology, 175 (2). pp. 1100-1106.

James, C.M., Bartlett, E.J., Mansfield, J.P. and Cull, V.S. (2005) Interferon subtype gene therapy for regulating cytomegalovirus disease. Methods in molecular medicine, 116 . pp. 207-219.

Bartlett, E.J., Lenzo, J.C., Sivamoorthy, S., Mansfield, J.P., Cull, V.S. and James, C.M. (2004) Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis. Immunology and Cell Biology, 82 (2). pp. 119-126.

Lenzo, J.C., Mansfield, J.P., Sivamoorthy, S., Cull, V.S. and James, C.M. (2003) Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy. Cellular Immunology, 223 (1). pp. 77-86.

Carr, D.J.J., Al-khatib, K., James, C.M. and Silverman, R. (2003) Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. Journal of Neuroimmunology, 141 (1-2). pp. 40-46.

Bartlett, E.J., Cull, V.S., Mowe, E.N., Mansfield, J.P. and James, C.M. (2003) Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection. Biological Procedures Online, 5 (1). pp. 43-52.

Lenzo, J.C., Fairweather, D., Cull, V., Shellam, G.R. and James, C.M. (2002) Characterisation of murine cytomegalovirus myocarditis: Cellular infiltration of the heart and virus persistence. Journal of Molecular and Cellular Cardiology, 34 (6). pp. 629-640.

Cull, V.S., Broomfield, S., Bartlett, E.J., Brekalo, N.L. and James, C.M. (2002) Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice. Gene Therapy, 9 (20). pp. 1369-1378.

Bartlett, E.J., Cull, V.S., Brekalo, N.L., Lenzo, J.C. and James, C.M. (2002) Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection. Immunology and Cell Biology, 80 (5). pp. 425-435.

Härle, P., Cull, V., Guo, L., Papin, J., Lawson, C. and Carr, D.J.J. (2002) Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Research, 56 (1). pp. 39-49.

Cull, V.S., Bartlett, E.J. and James, C.M. (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis. Immunology, 106 (3). pp. 428-437.

Lenzo, J.C. and Lawson, C.M. (2001) Cytomegalovirus-induced myocarditis - An animal model for understanding pathogenesis and therapy. International Antiviral News, 9 (11). pp. 166-169.

Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M. and Rose, N.R. (2001) From infection to autoimmunity. Journal of Autoimmunity, 16 (3). pp. 175-186.

Lenzo, J.C., Shellam, G.R. and Lawson, C.M. (2001) Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrobial agents and chemotherapy, 45 (5). pp. 1444-1449.

Lenzo, J.C., Fairweather, D., Shellam, G.R. and Lawson, C.M. (2001) Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cellular Immunology, 213 (1). pp. 52-61.

Lawson, C.M. (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cellular and Molecular Life Sciences, 57 (4). pp. 552-560.

Bosio, E., Beilharz, M.W., Watson, M.W. and Lawson, C.M. (1999) Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. Journal of Interferon & Cytokine Research, 19 (8). pp. 869-876.

Lawson, C.M. and Beilharz, M.W. (1999) Low-dose oral use of interferon inhibits virally induced myocarditis. Journal of Interferon & Cytokine Research, 19 (8). pp. 863-867.

Conference Paper

James, C.M., Lisciandro, J., Gerlach, N., Dittmer, U. and Stumbles, P.A. (2007) Interferon-alpha subtypes differentially enhance dendritic cell biology. In: International Society for Interferon and Cytokine Research, Interferon Anniversary Meeting, 16 - 19 September, Oxford, England

This list was generated on Fri Oct 31 17:55:28 2014 GMT.